> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection on Biologic Adverse Experience Reporting
- URL: https://www.fdaweb.com/info-collection-on-biologic-adverse-experience-reporting/
- Published: 2020-09-01T12:00:00.000Z
- Updated: 2026-09-14T16:27:09.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5147554

*Federal Register* notice: FDA is seeking comments on an information collection extension for “Adverse Experience Reporting For Licensed Biological Products; and General Records—21 CFR Part 600” (OMB Control Number 0910-0308). The collection supports FDA-issued adverse experience reporting requirements in part 600 (21 CFR part 600) to enable it to take actions necessary for the protection of public health. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-09-01/pdf/2020-19239.pdf?ref=fdaweb.com).